A statewide survey revealed that a majority of New York State's small business owners support health exchanges
NEW YORK-A recent statewide survey revealed that a majority of New York State's small business owners support health exchanges as a way to provide insurance to their employees, but will other state exchanges receive a similar response? According to industry experts, it's hard to say.
"I think the survey is very useful in understanding how it might be received by small businesses," says Vincent C. Ashton, president and CEO of HealthPass New York, the health exchange that commissioned the survey, "but I don't know that it will take the place of each state trying to get that direct sense of what their small businesses are looking for in a small business SHOP exchange, in order to make it a viable solution for them and their employees."
REAL WORLD PROOF
"There are a lot of entities and advocacy organizations, state officials and people who have been putting together [the Patient Protection and Affordable Care Act] in the first place, who all have theories about how this might work and how it will be received," Ashton says. "But I don't know that we had seen people actually reaching out directly to those who are going to be affected."
Out of 300 participating small business owners, each with 50 employees or fewer, 84% thought health insurance exchanges were a good idea. The survey also showed that while many small businesses are struggling, there is significant potential for modifying New York's healthcare marketplace with exchanges.
For example, only 27% of the small business owners reported that their own businesses are doing well, but 50% agree that if they didn't spend so much time dealing with their employees' healthcare, they could spend more time thinking about how to grow their business. Additionally, 76% said they would consider using an exchange when enrolling their employees in a health benefits program, and 60% that do not currently provide health insurance to their employees said they would be more likely to offer coverage if an exchange was available.
Ashton says that employers have some trepidation about the economy, and with healthcare in general, but it's pretty clear from the statistics that they are looking to start reining in some of the costs associated with healthcare. That said, there's no way to be certain that the thoughts of New York business owners will be the same as business owners in other insurance markets.
"It's not something that easily translates over state lines because of the differences in rules and regulations," says Ashton.
He says exchanges will establish a new marketplace with growth potential and the ability to attack the underlying costs of medical care, "which is really the main driver of what the problems with the cost of healthcare is in general."
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More